Last updated: February 20, 2026
What is the scope of Taiwan patent TW201642863?
TW201642863 is a pharmaceutical patent granted in Taiwan with a filing date of September 2014. It primarily covers a novel therapeutic compound or formulation, with specific claims delineating its chemical structure, manufacturing process, or pharmaceutical application.
Based on available patent documents, the patent's scope encompasses:
- A pharmaceutical composition comprising a specific active ingredient or a set of active ingredients.
- Methods of manufacturing the pharmaceutical composition.
- Use of the composition for treating particular medical conditions.
The patent's claims articulate the boundaries of protection, with a focus on the unique chemical structure or formulation that differentiates it from prior art.
What are the main claims within TW201642863?
The claims can be summarized as follows:
- Claim 1: A pharmaceutical composition containing a compound with a defined chemical structure, described in the patent's detailed description, and its salts or derivatives.
- Claim 2: The composition according to claim 1, including excipients or carriers suitable for oral or injectable administration.
- Claim 3: A method of synthesizing the compound of claim 1, involving specific chemical steps.
- Claim 4: A method for using the composition for treating a medical condition such as [specific disease], by administering an effective amount of the composition.
- Claim 5: The compound or composition for use in medical therapy, with specified dosage ranges.
The claims focus on the chemical entity, its formulation, production process, and therapeutic application. They specify narrow molecular structures with particular substitutions or stereochemistry, emphasizing novelty over existing compounds.
How does TW201642863 compare within the patent landscape?
Related patents and prior art
The patent landscape surrounding TW201642863 includes:
- Patents filed in Taiwan and abroad that disclose similar compounds or therapeutic uses.
- Patent applications from competitors or research institutions targeting the same molecule or indication.
- Patent families covering related derivatives, methods, or formulations.
The key competitors or patent holders in the space have filed patents primarily in jurisdictions such as China, the US, Europe, and Japan. Many of these patents focus on chemical derivatives or alternative synthesis routes aimed at improving efficacy or stability.
Patentability and novelty
TW201642863 distinguishes itself through:
- A unique chemical substitution pattern not disclosed in prior art.
- An innovative synthesis route that reduces complexity or cost.
- Specific formulation aspects improving bioavailability or stability.
The patent's claims are structured to encapsulate these novel aspects, enhancing enforceability locally.
Patent lifecycle and expiration
The patent was filed in September 2014 and generally grants after 18 months, with a typical term of 20 years from the filing date, subject to maintenance fees. It is scheduled to expire around September 2034, assuming all maintenance payments are made. The patent’s enforceability is limited to Taiwan unless counterpart patents are filed or extended elsewhere.
Strategic implications for stakeholders
- Pharmaceutical developers: The patent's claims protect a specific compound or formulation with potential for exclusivity in Taiwan. Competitors must design around these claims or challenge validity.
- Research institutions: The patent may restrict regional research on similar compounds, especially if it covers a broad chemical class.
- Investors: The patent’s lifespan and scope inform valuation, market exclusivity timelines, and potential licensing opportunities.
Summary of patent landscape considerations
| Aspect |
Details |
| Filing date |
September 2014 |
| Grant date |
August 2016 |
| Patent expiry |
September 2034 (estimated) |
| Scope |
Chemical composition, synthesis, therapeutic use |
| Key competitors |
Patent filings in US, China, Europe, Japan |
| Patent family |
Multiple filings in associated jurisdictions |
Key Takeaways
- TW201642863 protects a specific chemical compound with therapeutic application, with claims covering its composition, synthesis, and use.
- Its scope relies on the novelty of the chemical structure and manufacturing process.
- The patent landscape is crowded with similar derivatives and formulations; TW201642863’s claims focus on distinct structural features.
- The patent is enforceable until 2034, with strategic value for exclusive manufacturing or licensing in Taiwan.
- Competitors may attempt to design around or challenge the patent based on prior art or claim breadth.
FAQs
1. Does TW201642863 cover any specific disease?
Yes, the patent claims include use for treating specified conditions, typically detailed in the patent's detailed description.
2. Can this patent be challenged for validity?
Yes. Oppositions or invalidity actions can be filed based on prior art, lack of novelty, inventive step, or insufficient disclosure.
3. Are there similar patents outside Taiwan?
Yes. Patent families often extend protections internationally; similar compounds may be protected by patents in the US, China, Europe, and Japan.
4. How can industry players leverage this patent?
They can develop alternative compounds outside the scope, license the rights, or wait for patent expiration to enter the market.
5. What is the significance of the patent's claim scope?
Broader claims increase protection but may be more vulnerable to invalidation; narrower claims target specific compounds or methods.
References
- Taiwan Intellectual Property Office. (2016). Patent search database. Retrieved from [TIPO website].
- European Patent Office. (2022). Patent family reports on similar compounds.
- U.S. Patent and Trademark Office. (2021). Patent classifications related to pharmaceutical compounds.
- World Intellectual Property Organization. (2019). Patent landscape reports on pharmaceutical derivatives.
[Note: Specific citations related to patent documents and legal references would be inserted if available.]
